X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
male (14) 14
index medicus (13) 13
oncology (12) 12
aged (8) 8
middle aged (8) 8
adult (7) 7
treatment outcome (6) 6
chemotherapy (5) 5
female (5) 5
prostate cancer (5) 5
abiraterone acetate (4) 4
antineoplastic agents - therapeutic use (4) 4
antitumor-activity (4) 4
cancer (4) 4
diagnosis (4) 4
retrospective studies (4) 4
aged, 80 and over (3) 3
androstenols - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
circulating tumor-cells (3) 3
clinical-trial (3) 3
cyp17 (3) 3
disease-free survival (3) 3
i clinical-trial (3) 3
neoplasm metastasis (3) 3
phase-ii trial (3) 3
prednisone (3) 3
prostatic neoplasms - drug therapy (3) 3
prostatic neoplasms - pathology (3) 3
pyrimidines - therapeutic use (3) 3
urology & nephrology (3) 3
abiraterone (2) 2
abridged index medicus (2) 2
acetate (2) 2
androgen receptor (2) 2
androstenes (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
article (2) 2
biosensors (2) 2
carcinoma, renal cell - drug therapy (2) 2
cellular immunotherapy (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
endothelial growth-factor (2) 2
gene expression (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
human cytochrome p450 (2) 2
hypertension (2) 2
inhibitor (2) 2
interferon-alpha (2) 2
kaplan-meier estimate (2) 2
kidney neoplasms - drug therapy (2) 2
medical research (2) 2
metastases (2) 2
neoplasms - drug therapy (2) 2
nonreceptor tyrosine kinases (2) 2
nucleic acids (2) 2
orchiectomy (2) 2
patients (2) 2
peptides (2) 2
pharmacology & pharmacy (2) 2
phenylthiohydantoin - analogs & derivatives (2) 2
pilot projects (2) 2
plus prednisone (2) 2
positron-emission tomography (2) 2
prostate (2) 2
prostatic neoplasms - diagnosis (2) 2
prostatic neoplasms, castration-resistant - pathology (2) 2
pyrimidines - pharmacology (2) 2
randomized controlled-trial (2) 2
research (2) 2
resistant prostate-cancer (2) 2
scintigraphy (2) 2
second-line treatment (2) 2
steroid 17-alpha-hydroxylase - antagonists & inhibitors (2) 2
steroidal inhibitors (2) 2
sulfonamides - pharmacology (2) 2
sulfonamides - therapeutic use (2) 2
survival rate (2) 2
targeted therapy (2) 2
therapy (2) 2
tomography, x-ray computed (2) 2
acetic acid (1) 1
administration, oral (1) 1
advanced (1) 1
advanced solid tumors (1) 1
american-society (1) 1
amplification (1) 1
analysis (1) 1
analytical chemistry (1) 1
androgen antagonists - administration & dosage (1) 1
androgen antagonists - adverse effects (1) 1
androgen antagonists - chemistry (1) 1
androgen antagonists - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 21, pp. 1995 - 2005
Journal Article
Clinical Chemistry and Laboratory Medicine (CCLM), ISSN 1434-6621, 09/2019, Volume 57, Issue 10, pp. 253 - 254
Journal Article
BJU International, ISSN 1464-4096, 01/2012, Volume 109, Issue 2, pp. 200 - 206
Study Type – Therapy (individual cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Sorafenib is an oral receptor tyrosine... 
second‐line treatment | prognostic and predictive markers | renal cell carcinoma | second-line treatment | DIAGNOSIS | EVEROLIMUS | BEVACIZUMAB | FOLLOW-UP | ANTITUMOR-ACTIVITY | TRIAL | INTERFERON-ALPHA | THERAPY | SUNITINIB | UROLOGY & NEPHROLOGY | GASTROINTESTINAL STROMAL TUMORS | Niacinamide - analogs & derivatives | Prognosis | Humans | Middle Aged | Male | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Hand-Foot Syndrome - etiology | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Neoplasm Metastasis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Carcinoma, Renal Cell - drug therapy | Pyridines - administration & dosage | Carcinoma, Renal Cell - pathology | Treatment Outcome | Mucositis - chemically induced | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Salvage Therapy - methods | Tyrosine | Hypertension | Medical colleges | Medical research | Care and treatment | Metastasis | Carcinoma, Renal cell | Antineoplastic agents | Endothelium | Antimitotic agents | Analysis | Medicine, Experimental | Dosage and administration | Vascular endothelial growth factor | Phosphotransferases | Cancer | Mutation | Patients
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e16558 - e16558
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 108 - 108
108 Background: Prostate cancer (PCa) is the most commonly diagnosed cancer in men. Around 80% of PCas are diagnosed as early, localised stage yet a subset of... 
Journal Article
Radiology, ISSN 0033-8419, 07/2016, Volume 280, Issue 1, pp. 151 - 160
Purpose: To determine the correlation between the volume of bone metastasis as assessed with diffusion-weighted (DW) imaging and established prognostic factors... 
COEFFICIENT | BIOMARKER | ONCOLOGY | MRI | PET/CT | SCINTIGRAPHY | CELLULARITY | POPULATION-BASED ANALYSIS | PATTERNS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SPECT
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 8, pp. 767 - 768
Journal Article
Analytical Chemistry, ISSN 0003-2700, 08/2016, Volume 88, Issue 16, p. 8091
  Highly abundant in cells, microRNAs (or miRs) play a key role as regulators of gene expression. A proportion of them are also detectable in biofluids making... 
Polymerase chain reaction | Peptides | Gene expression | Ribonucleic acid--RNA | Biosensors | Cells
Journal Article
Analytical Chemistry (Washington), ISSN 0003-2700, 08/2016, Volume 88, Issue 16, pp. 8091 - 8091
Highly abundant in cells, microRNAs (or miRs) play a key role as regulators of gene expression. A proportion of them are also detectable in biofluids making... 
Journal Article
Analytical Chemistry (Washington), ISSN 0003-2700, 08/2016, Volume 88, Issue 16, pp. 8091 - 8091
Highly abundant in cells, microRNAs (or miRs) play a key role as regulators of gene expression. A proportion of them are also detectable in biofluids making... 
Amplification | Ribonucleic acids | Peptides | Biomarkers | Nucleic acids | Biosensors | Prostate | Cancer
Journal Article
Journal of Algorithms and Computational Technology, ISSN 1748-3018, 12/2016, Volume 10, Issue 4, pp. 290 - 301
A novel post-processing methodology able to assess whole-body tumor heterogeneity in patients with metastatic disease is proposed. The method is demonstrated... 
Apparent diffusion coefficient and fractional enhancement | Tumor heterogeneity | Whole-body magnetic resonance | Probabilistic image interpretation | Metastases
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2014, Volume 20, Issue 23, pp. 5908 - 5917
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 5_suppl, pp. 17 - 17
17 Background: Abiraterone acetate (AA) has recently been approved for men with metastatic castration-resistant prostate cancer (CRPC) following docetaxel... 
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 09/2012, Volume 11, Issue 5, pp. 851 - 859
Journal Article